Encision continues to trim losses
BOULDER — Encision Inc. (PK: ECIA), a Boulder-based medical device company that owns patented surgical technology designed to prevent stray electrosurgical burns during minimally invasive surgery, on Monday posted net revenue of $2.289 million and a net loss of $282,000 for its fourth quarter that ended March 31.
That loss, which amounted to 3 cents per share, compares with revenue of $2.307 million and a net loss of $349,000, or 3 cents a share, in the same quarter a year ago.
Gross margin on net revenue was 45.8 percent in the fiscal 2016 fourth quarter and 51.2 percent in the fiscal 2015 fourth quarter.
SPONSORED CONTENT
Federal District Court Rules Corporate Transparency Act Unconstitutional . . . But Most Small Businesses Must Still Comply
Lyons Gaddis Real Estate and Business Attorney Cameron Grant shares important details of the Corporate Transparency Act (CTA).
For the just-ended fiscal year, the company posted net revenue of $9.336 million and a net loss of $880,000 or 8 cents per share. These results compare with net revenue of $9.671 million and a net loss of $1.383 million, or $ 13 cents per share, in the same quarter a year ago.
“Continued improvements by our manufacturing operations are narrowing the gap on losses as we drive to profitability,” said Greg Trudel, Encision’s president and chief executive, in a statement that accompanied the earnings report. “Our gross margins progressively improved throughout FY16 despite reduced volumes. We have eliminated legacy inventories of obsolete and slow moving products and are in a position for a promising FY17.”
